221 related articles for article (PubMed ID: 16741062)
1. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of the endothelin axis in ovarian tumor progression.
Bagnato A; Spinella F; Rosanò L
Endocr Relat Cancer; 2005 Dec; 12(4):761-72. PubMed ID: 16322321
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
[TBL] [Abstract][Full Text] [Related]
7. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
Rosanò L; Di Castro V; Spinella F; Decandia S; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1132-5. PubMed ID: 16741063
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
Spinella F; Rosanò L; Decandia S; Di Castro V; Albini A; Elia G; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1123-7. PubMed ID: 16741061
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in ovarian cancer.
Vergara D; Merlot B; Lucot JP; Collinet P; Vinatier D; Fournier I; Salzet M
Cancer Lett; 2010 May; 291(1):59-66. PubMed ID: 19880243
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
Kajiyama H; Shibata K; Terauchi M; Yamashita M; Ino K; Nawa A; Kikkawa F
Int J Oncol; 2007 Aug; 31(2):277-83. PubMed ID: 17611683
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
Yang AD; Camp ER; Fan F; Shen L; Gray MJ; Liu W; Somcio R; Bauer TW; Wu Y; Hicklin DJ; Ellis LM
Cancer Res; 2006 Jan; 66(1):46-51. PubMed ID: 16397214
[TBL] [Abstract][Full Text] [Related]
15. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.
Salani D; Rosanò L; Di Castro V; Spinella F; Venuti A; Padley RJ; Nicotra MR; Natali PG; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():318S-321S. PubMed ID: 12193113
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.
Collino F; Revelli A; Massobrio M; Katsaros D; Schmitt-Ney M; Camussi G; Bussolati B
Exp Cell Res; 2009 Oct; 315(17):2982-94. PubMed ID: 19538958
[TBL] [Abstract][Full Text] [Related]
17. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
Christiansen JJ; Rajasekaran AK
Cancer Res; 2006 Sep; 66(17):8319-26. PubMed ID: 16951136
[TBL] [Abstract][Full Text] [Related]
18. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract][Full Text] [Related]
19. Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line.
Maines-Bandiera SL; Huntsman D; Lestou VS; Kuo WL; Leung PC; Horsman RD; Wong AS; Woo MM; Choi KK; Roskelley CD; Auersperg N
Differentiation; 2004 Apr; 72(4):150-61. PubMed ID: 15157238
[TBL] [Abstract][Full Text] [Related]
20. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
